Compare $ALT vs $RZLT | Chartloom

Compare

$ALT vs $RZLT

Altimmune Inc · Rezolute Inc

ALT

Altimmune Inc

RZLT

Rezolute Inc

Compare $ALT vs $RZLT

Comparing Altimmune Inc and Rezolute Inc

ALTAltimmune Inc

RZLTRezolute Inc

ALTAltimmune Inc

Market cap

$508M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

55.0%

YTD performance

-25.6%

52W performance

-33.6%

FCF yield

-15.1%

RZLTRezolute Inc

Market cap

$469M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

124.9%

52W performance

-44.2%

FCF yield

-13.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALT

RZLT

Detailed metrics comparison

ALT

Altimmune Inc

RZLT

Rezolute Inc

Market Cap

ALT$508M

RZLT$469M

Enterprise Value

ALT$479M

RZLT$458M

Price

ALT$2.61

RZLT$4.87

P/E Ratio

ALTN/A

RZLTN/A

P/S Ratio

ALT16,373.12x

RZLT0.00x

EV/Sales

ALT15,461.31x

RZLT0.00x

EV/EBITDA

ALT0.00x

RZLT0.00x

P/B Ratio

ALT1.12x

RZLT3.85x

P/FCF Ratio

ALTN/A

RZLTN/A

EV/FCF

ALT-6.26x

RZLT-7.09x

PEG Ratio

ALTN/A

RZLTN/A

Forward P/E (NTM)

ALTN/A

RZLTN/A

Forward P/S (NTM)

ALTN/A

RZLTN/A

Revenue (TTM)

ALT$31K

RZLT$0

Revenue Growth (YoY)

ALT55.0%

RZLTN/A

Forward Rev Growth

ALT217.1%

RZLT2194.8%

Gross Margin (TTM)

ALT0.0%

RZLT0.0%

Operating Margin (TTM)

ALT0.0%

RZLT0.0%

EBITDA Margin (TTM)

ALT-322987.1%

RZLT0.0%

Net Margin (TTM)

ALT-296000.0%

RZLT0.0%

FCF Margin (TTM)

ALT-246974.2%

RZLTN/A

Net Income (TTM)

ALT$-92M

RZLT$-78M

FCF (TTM)

ALT$-77M

RZLT$-65M

EPS (TTM)

ALT-$0.49

RZLT-$0.74

ROE (TTM)

ALT-3141.0%

RZLT-6299.0%

ROA (TTM)

ALT-2696.0%

RZLT-5794.0%

ROIC (TTM)

ALT-2853.0%

RZLT-6299.0%

Cash

ALT$63M

RZLT$11M

Debt

ALT$35M

RZLT$0

Net Cash/Debt

ALT$28M

RZLT$11M

Current Ratio (TTM)

ALT26.78x

RZLT9.68x

Quick Ratio (TTM)

ALT26.37x

RZLT9.44x

Debt/Equity (TTM)

ALT0.07x

RZLT0.00x

Debt/Assets (TTM)

ALT0.0%

RZLT0.0%

Interest Coverage (TTM)

ALTN/A

RZLTN/A

Net Debt/EBITDA (TTM)

ALT0.00x

RZLT0.00x

Beta

ALT0.06

RZLT0.58

52W Performance

ALT-33.6%

RZLT-44.2%

YTD Performance

ALT-25.6%

RZLT124.9%

% from 52W High

ALT-59.5%

RZLT-57.5%

% from 52W Low

ALT2.4%

RZLT355.1%

Asset Turnover (TTM)

ALT0.00x

RZLT0.00x

FCF Yield (TTM)

ALT-15.1%

RZLT-13.8%

Earnings Yield (TTM)

ALT-18.1%

RZLT-16.5%

Dividend Yield (TTM)

ALTN/A

RZLTN/A

Rule of 40

ALT-246,919.2

RZLT0.0

EV/GP/RG

ALTN/A

RZLTN/A

Ticker research

View ALT research View RZLT research

Metric	ALT Altimmune Inc	RZLT Rezolute Inc
Market & Valuation
Market Cap	$508M	$469M
Enterprise Value	$479M	$458M
Price	$2.61	$4.87
P/E Ratio	N/A	N/A
P/S Ratio	16,373.12x	0.00x
EV/Sales	15,461.31x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.12x	3.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.26x	-7.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$31K	$0
Revenue Growth (YoY)	55.0%	N/A
Forward Rev Growth	217.1%	2194.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-322987.1%	0.0%
Net Margin (TTM)	-296000.0%	0.0%
FCF Margin (TTM)	-246974.2%	N/A
Net Income (TTM)	$-92M	$-78M
FCF (TTM)	$-77M	$-65M
EPS (TTM)	-$0.49	-$0.74
ROE (TTM)	-3141.0%	-6299.0%
ROA (TTM)	-2696.0%	-5794.0%
ROIC (TTM)	-2853.0%	-6299.0%
Financial Health
Cash	$63M	$11M
Debt	$35M	$0
Net Cash/Debt	$28M	$11M
Current Ratio (TTM)	26.78x	9.68x
Quick Ratio (TTM)	26.37x	9.44x
Debt/Equity (TTM)	0.07x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.06	0.58
52W Performance	-33.6%	-44.2%
YTD Performance	-25.6%	124.9%
% from 52W High	-59.5%	-57.5%
% from 52W Low	2.4%	355.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-15.1%	-13.8%
Earnings Yield (TTM)	-18.1%	-16.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-246,919.2	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALT research	View RZLT research

Valuation

P/S Ratio

RZLT

0.00x

ALT

16,373.12x

EV/FCF

RZLT

-7.09x

ALT

-6.26x

Growth & revenue

Revenue Growth TTM

ALT

55.0%

Forward Revenue Growth

RZLT

2194.8%

ALT

217.1%

Profitability & performance

Gross Margin

ALT

0.0%

RZLT

0.0%

ROE

ALT

-3141.0%

RZLT

-6299.0%

FCF Yield %

RZLT

-13.8%

ALT

-15.1%

52-Week Performance

ALT

-33.6%

RZLT

-44.2%

Detailed metrics comparison

ALT

Altimmune Inc

RZLT

Rezolute Inc

Market Cap

ALT$508M

RZLT$469M

Enterprise Value

ALT$479M

RZLT$458M

Price

ALT$2.61

RZLT$4.87

P/E Ratio

ALTN/A

RZLTN/A

P/S Ratio

ALT16,373.12x

RZLT0.00x

EV/Sales

ALT15,461.31x

RZLT0.00x

EV/EBITDA

ALT0.00x

RZLT0.00x

P/B Ratio

ALT1.12x

RZLT3.85x

P/FCF Ratio

ALTN/A

RZLTN/A

EV/FCF

ALT-6.26x

RZLT-7.09x

PEG Ratio

ALTN/A

RZLTN/A

Forward P/E (NTM)

ALTN/A

RZLTN/A

Forward P/S (NTM)

ALTN/A

RZLTN/A

Revenue (TTM)

ALT$31K

RZLT$0

Revenue Growth (YoY)

ALT55.0%

RZLTN/A

Forward Rev Growth

ALT217.1%

RZLT2194.8%

Gross Margin (TTM)

ALT0.0%

RZLT0.0%

Operating Margin (TTM)

ALT0.0%

RZLT0.0%

EBITDA Margin (TTM)

ALT-322987.1%

RZLT0.0%

Net Margin (TTM)

ALT-296000.0%

RZLT0.0%

FCF Margin (TTM)

ALT-246974.2%

RZLTN/A

Net Income (TTM)

ALT$-92M

RZLT$-78M

FCF (TTM)

ALT$-77M

RZLT$-65M

EPS (TTM)

ALT-$0.49

RZLT-$0.74

ROE (TTM)

ALT-3141.0%

RZLT-6299.0%

ROA (TTM)

ALT-2696.0%

RZLT-5794.0%

ROIC (TTM)

ALT-2853.0%

RZLT-6299.0%

Cash

ALT$63M

RZLT$11M

Debt

ALT$35M

RZLT$0

Net Cash/Debt

ALT$28M

RZLT$11M

Current Ratio (TTM)

ALT26.78x

RZLT9.68x

Quick Ratio (TTM)

ALT26.37x

RZLT9.44x

Debt/Equity (TTM)

ALT0.07x

RZLT0.00x

Debt/Assets (TTM)

ALT0.0%

RZLT0.0%

Interest Coverage (TTM)

ALTN/A

RZLTN/A

Net Debt/EBITDA (TTM)

ALT0.00x

RZLT0.00x

Beta

ALT0.06

RZLT0.58

52W Performance

ALT-33.6%

RZLT-44.2%

YTD Performance

ALT-25.6%

RZLT124.9%

% from 52W High

ALT-59.5%

RZLT-57.5%

% from 52W Low

ALT2.4%

RZLT355.1%

Asset Turnover (TTM)

ALT0.00x

RZLT0.00x

FCF Yield (TTM)

ALT-15.1%

RZLT-13.8%

Earnings Yield (TTM)

ALT-18.1%

RZLT-16.5%

Dividend Yield (TTM)

ALTN/A

RZLTN/A

Rule of 40

ALT-246,919.2

RZLT0.0

EV/GP/RG

ALTN/A

RZLTN/A

Ticker research

View ALT research View RZLT research

Metric	ALT Altimmune Inc	RZLT Rezolute Inc
Market & Valuation
Market Cap	$508M	$469M
Enterprise Value	$479M	$458M
Price	$2.61	$4.87
P/E Ratio	N/A	N/A
P/S Ratio	16,373.12x	0.00x
EV/Sales	15,461.31x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.12x	3.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.26x	-7.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$31K	$0
Revenue Growth (YoY)	55.0%	N/A
Forward Rev Growth	217.1%	2194.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-322987.1%	0.0%
Net Margin (TTM)	-296000.0%	0.0%
FCF Margin (TTM)	-246974.2%	N/A
Net Income (TTM)	$-92M	$-78M
FCF (TTM)	$-77M	$-65M
EPS (TTM)	-$0.49	-$0.74
ROE (TTM)	-3141.0%	-6299.0%
ROA (TTM)	-2696.0%	-5794.0%
ROIC (TTM)	-2853.0%	-6299.0%
Financial Health
Cash	$63M	$11M
Debt	$35M	$0
Net Cash/Debt	$28M	$11M
Current Ratio (TTM)	26.78x	9.68x
Quick Ratio (TTM)	26.37x	9.44x
Debt/Equity (TTM)	0.07x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.06	0.58
52W Performance	-33.6%	-44.2%
YTD Performance	-25.6%	124.9%
% from 52W High	-59.5%	-57.5%
% from 52W Low	2.4%	355.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-15.1%	-13.8%
Earnings Yield (TTM)	-18.1%	-16.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-246,919.2	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ALT research	View RZLT research